Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

MoFo advised Carlsmed, Inc. in connection with its US$10 million Series A financing led by U.S. Venture Partners (USVP). Carlsmed will use the financing to commercialize the aprevo family of spine deformity correction devices.

MoFo Represents Carlsmed, Inc. in its Series A Financing

About Morrison Forester

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

MoFo advised Carlsmed, Inc. in connection with its US$10 million Series A financing led by U.S. Venture Partners (USVP). Carlsmed will use the financing to commercialize the aprevo family of spine deformity correction devices. Carlsmed was recently granted 510(k) clearance and Breakthrough Device Designation by the FDA for aprevo, making it the first implant ever to receive both Breakthrough Device Designation and 510(k) market clearance from the FDA. USVP is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies.The MoFo team was led by San Diego partner Jim Krenn, and associates Brennen Brodersen and Carey Hughes. Additional support was provided by Government Contracts & Public Procurement partners Charles Capito and Tina Reynolds, as well as Federal Tax partner Shane Shelley, National Security Compliance partner Panagiotis Bayz, Emerging Companies & Venture Capital partner Steve Rowles, and Executive Compensation partner Amanda Hines Gold.Read more about the transaction in the company’s <a href="https://www.businesswire.com/news/home/20201216005209/en/Carlsmed-Raises-10M-to-Commercialize-Breakthrough-aprevo%E2%84%A2-Devices" target="_blank">press release</a>.